Medgenics, Inc. announced the appointment of Rick Couch, Ph.D., as Vice President of Chemistry, Manufacturing and Controls (CMC). In this role, Dr. Couch will be a key member in setting the strategy and tactics of technical product development as well as leading and managing all CMC activities. Dr. Couch has held positions of increasing responsibility in the Pharmaceutical Sciences, most recently at Shire Pharmaceuticals, where his teams were responsible for the Pharmaceutical Development of several products including Carbatrol(r), Adderall XR(r), Intuniv(r) and SHP465.